Nitinotes
Develops safe, effective and long-lasting minimally invasive solutions for treating obesity.
Launch date
Employees
Market cap
-
Enterprise valuation
€37—55m (Dealroom.co estimates Sep 2023.)
Company register number 515065753
Caesarea Haifa District (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$4.1m | Seed | ||
$2.6m | Series A | ||
| N/A | $5.1m | Series A | |
* | N/A | $10.1m | Series B |
| Total Funding | €19.9m | ||
Recent News about Nitinotes
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.